stearyl tyrosine has been researched along with HIV in 1 studies
*HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bona, CA; Dionne, G; Ethier, D; Jennings, H; Michon, F; Nixon-George, A; Penney, CL; Zaghouani, H | 1 |
1 other study(ies) available for stearyl tyrosine and HIV
| Article | Year |
|---|---|
Further studies on the adjuvanticity of stearyl tyrosine and ester analogues.
Topics: Adjuvants, Immunologic; Amino Acid Sequence; Amino Acids; Animals; Antibody Formation; Antibody Specificity; Esters; Female; Hepatitis B Surface Antigens; HIV; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neisseria meningitidis; Oligopeptides; Poliovirus; Toxoids; Tyrosine; Viral Proteins | 1993 |